IGF1R and gastric cancer: Therefore, the effect cannot be explained by off-target effects, e.g., by cetuximab binding and paradoxical stimulation of Insulin-like growth factor 1 receptor, a mechanism that has been proposed in the context of cetuximab resistance in gastric cancer (32).